Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|August 19, 2014
A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptideAthanasios Kotsakis, Elisavet Papadimitraki, Eleni Kyriaki Vetsika, et al.Plos One|September 24, 2013
Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposideNiki Karachaliou, Chara Papadaki, Eleni Lagoudaki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancerChara Papadaki, Maria Sfakianaki, Georgios Ioannidis, et al.Cancer Chemotherapy and Pharmacology|October 26, 2007
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumorsKostas Kalbakis, Periklis Pappas, Charalambos Kouroussis, et al.International Journal of Cancer|August 28, 2007
Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activationXanthi N Stahtea, Andeas E Roussidis, Ioannis Kanakis, et al.Breast Cancer Research : BCR|June 14, 2011
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapseEmmanouil Saloustros, Maria Perraki, Stella Apostolaki, et al.Cancer Chemotherapy and Pharmacology|May 19, 2011
A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancerZacharenia Saridaki, Nikolaos Malamos, Panagiotis Kourakos, et al.Lung Cancer (Amsterdam, Netherlands)|June 3, 2011
Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosisIoannis Gioulbasanis, Panagiotis Georgoulias, Panagiotis J Vlachostergios, et al.Cancers|December 16, 2020
Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical OutcomeHara Polioudaki, Anastasia Mala, Eleni Gkimprixi, et al.Anticancer Research|April 4, 2008
Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)Antonia Kalykaki, Pavlos Papakotoulas, Sofoklis Tsousis, et al.Pageof 12